Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Voyager Therapeutics Yönetim
Yönetim kriter kontrolleri 3/4
Voyager Therapeutics' CEO is Al Sandrock, appointed in Mar 2022, has a tenure of 2.58 years. total yearly compensation is $3.17M, comprised of 19.7% salary and 80.3% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $367.61K. The average tenure of the management team and the board of directors is 2.1 years and 4.7 years respectively.
Anahtar bilgiler
Al Sandrock
İcra Kurulu Başkanı
US$3.2m
Toplam tazminat
CEO maaş yüzdesi | 19.7% |
CEO görev süresi | 2.6yrs |
CEO sahipliği | 0.1% |
Yönetim ortalama görev süresi | 2.1yrs |
Yönetim Kurulu ortalama görev süresi | 4.7yrs |
Son yönetim güncellemeleri
Recent updates
Voyager Therapeutics: CNS Player In Early Stages Of A Turnaround
Aug 26Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 09Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S
Aug 08Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis
Jun 05There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise
Mar 15Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
Mar 08What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates
Mar 04Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement
Jan 04Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target
Oct 04Voyager Therapeutics hires new finance chief
Sep 07Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02
Aug 04Looking Back In On Voyager Therapeutics
Jun 08Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates
May 12Voyager Does A Reboot After First Generation Failures
Mar 25Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky
Feb 07Voyager Therapeutics: Another Year, Another Deal
Nov 21CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$9m |
Mar 31 2024 | n/a | n/a | -US$3m |
Dec 31 2023 | US$3m | US$624k | US$132m |
Sep 30 2023 | n/a | n/a | US$52m |
Jun 30 2023 | n/a | n/a | US$96m |
Mar 31 2023 | n/a | n/a | US$99m |
Dec 31 2022 | US$7m | US$525k | -US$46m |
Tazminat ve Piyasa: Al's total compensation ($USD3.17M) is above average for companies of similar size in the US market ($USD2.40M).
Tazminat ve Kazançlar: Al's compensation has been consistent with company performance over the past year.
CEO
Al Sandrock (66 yo)
2.6yrs
Görev süresi
US$3,172,433
Tazminat
Dr. Alfred W. Sandrock Jr., also known as Al, M.D., Ph D., served as Director at Verge Analytics, Inc. since February 2022. He served as Member of Scientific Advisory Board at Camp4 Therapeutics Corporatio...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 2.6yrs | US$3.17m | 0.12% $ 367.6k | |
COO & Acting Chief Business Officer | no data | US$1.38m | 0.062% $ 197.0k | |
Chief Legal Officer | 1.3yrs | US$1.91m | 0% $ 0 | |
Founder | no data | Veri yok | Veri yok | |
Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Founder | no data | Veri yok | Veri yok | |
Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Chief Financial Officer | less than a year | Veri yok | Veri yok | |
Chief Scientific Officer | 2.1yrs | Veri yok | 0.16% $ 512.6k | |
Chief Human Resources Officer | 4.1yrs | Veri yok | Veri yok | |
Chief Corporate Affairs Officer & Chief of Staff to the CEO | 2.8yrs | Veri yok | Veri yok | |
Chief Medical Officer | less than a year | Veri yok | Veri yok |
2.1yrs
Ortalama Görev Süresi
53.5yo
Ortalama Yaş
Deneyimli Yönetim: VYGR's management team is considered experienced (2.1 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 2.7yrs | US$3.17m | 0.12% $ 367.6k | |
Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Consultant & Member of Scientific Advisory Board | 5.3yrs | US$1.81m | Veri yok | |
Independent Director | 10.8yrs | US$263.78k | 0.10% $ 319.3k | |
Independent Director | 7.8yrs | US$248.78k | 0.040% $ 127.4k | |
Independent Director | 9.1yrs | US$255.78k | 0% $ 0 | |
Independent Chairman of the Board | 9.3yrs | US$281.28k | 0.057% $ 183.2k | |
Independent Director | 2.3yrs | US$250.78k | 0% $ 0 | |
Director | 1.7yrs | US$452.32k | 0.0053% $ 17.0k | |
Independent Director | 1.8yrs | US$432.23k | 0% $ 0 | |
Independent Director | 4.1yrs | US$255.28k | 0% $ 0 |
4.7yrs
Ortalama Görev Süresi
64.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: VYGR's board of directors are considered experienced (4.7 years average tenure).